Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (Q38090905)

28 August 2017

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (English)

1 reference

28 August 2017

cardiovascular disease

1 reference

Quentin M Anstee

1

1 reference

28 August 2017

Giovanni Targher

series ordinal

2

1 reference

28 August 2017

Christopher P Day

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

19 March 2013

1 reference

Nature Reviews Gastroenterology & Hepatology

28 August 2017

1 reference

28 August 2017

10

1 reference

28 August 2017

330-344

1 reference

28 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2013.41

28 August 2017

0 references

cites work

How big a problem is non-alcoholic fatty liver disease?

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Non-alcoholic fatty liver disease: the mist gradually clears

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

AGA technical review on nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

A position statement on NAFLD/NASH based on the EASL 2009 special conference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease: a review of current understanding and future impact

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The importance of fatty liver disease in clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Epidemiology and natural history of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

American Gastroenterological Association medical position statement: evaluation of liver chemistry tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The utility of radiological imaging in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver biopsy findings from healthy potential living liver donors: Reasons for disqualification, silent diseases and correlation with liver injury tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The epidemiology of fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Fatty liver: a novel component of the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

From the metabolic syndrome to NAFLD or vice versa?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver fat in the metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Gamma-glutamyltransferase and diabetes--a 4 year follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The association of fatty liver and diabetes risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Long-term follow-up of patients with NAFLD and elevated liver enzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Gene expression in human NAFLD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The relationship between arterial stiffness and nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Carotid artery intima-media thickness in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Fatty liver index, gamma-glutamyltransferase, and early carotid plaques.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Assessment of endothelial function in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Sonographic fatty liver, overweight and ischemic heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver: an alarm for the heart?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Presence of coronary plaques in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Long term prognosis of fatty liver: risk of chronic liver disease and death.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Long-term follow-up of patients with nonalcoholic fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver fibrosis in overweight patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic steatohepatitis: a study of 49 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic steatohepatitis: an expanded clinical entity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Newly diagnosed diabetes mellitus as a risk factor for serious liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Population-based risk factors and resource utilization for HCC: US perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The global health burden of infection-associated cancers in the year 2002

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Obesity and cancer risk: a Danish record-linkage study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver fat in the pathogenesis of insulin resistance and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The adipocyte as an active participant in energy balance and metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Obesity, Inflammation, and Insulin Resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Causes and metabolic consequences of Fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Apoptosis and necrosis in the liver: a tale of two deaths?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genetics of alcoholic and nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genome-wide association studies in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genetic modifiers of non-alcoholic fatty liver disease progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

A Germline DNA Polymorphism Enhances Alternative Splicing of theKLF6Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

A common variant in the adiponutrin gene influences liver enzyme values

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Cholesterol and nonalcoholic fatty liver disease: renewed focus on an old villain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

METABOLIC OBSERVATIONS IN PATIENTS WITH JEJUNOCOLIC SHUNTS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Liver dysfunction after intestinal bypass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Elevated endotoxin levels in non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genomic approaches to studying the human microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The role of the gut microbiota in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Functional interactions between the gut microbiota and host metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.41

Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis.

31 March 2020

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies

1 reference

12 December 2020

Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?

1 reference

12 December 2020

Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2013.41

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference